NDC00002-5136-48: LORACARBEF FOR ORAL SUSPENSION.
The LORACARBEF FOR ORAL SUSPENSION is a the manufacturer industrial component. Key specifications include special_features: 200 MG LORACARBEF PER 5 ML,100 ML BOTTLE;THPE TO LORABID BY ELI-LILY;LYOPHILIZED POWDER;FOR ANTOBIOTIC USE, part_name_assigned_by_controlling_agency: LORACARBEF FOR ORAL SUSPENSION 200MG/5ML 100ML BT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-382-2804, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | 200 MG LORACARBEF PER 5 ML,100 ML BOTTLE;THPE TO LORABID BY ELI-LILY;LYOPHILIZED POWDER;FOR ANTOBIOTIC USE |
| part_name_assigned_by_controlling_agency | LORACARBEF FOR ORAL SUSPENSION 200MG/5ML 100ML BT |
| NSN | 6505-01-382-2804 |
| SPECIAL FEATURES | 200 MG LORACARBEF PER 5 ML,100 ML BOTTLE;THPE TO LORABID BY ELI-LILY;LYOPHILIZED POWDER;FOR ANTOBIOTIC USE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LORACARBEF FOR ORAL SUSPENSION 200MG/5ML 100ML BT |